| Nwosu, Benjamin U |
NCT06103513: Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children |
|
|
| Recruiting | 3 | 50 | US | Somatropin, Norditropin, Nutropin AQ, Genotropin, Zomacton, Humatrope, Omnitrope. | Northwell Health | Growth Disorders, Growth Failure, Growth Hormone Treatment, Growth | 06/25 | 12/25 | | |
NCT05714059: Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM |
|
|
| Completed | N/A | 250 | US | Insulin Pump with Continuous Glucose Monitoring | Medtronic Diabetes | Type 1 Diabetes | 12/23 | 12/23 | | |
NCT06719531: SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients with Type 1 and Type 2 Diabetes |
|
|
| Not yet recruiting | N/A | 1500 | US | Continuous Glucose Monitoring | Medtronic Diabetes | Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus | 12/25 | 12/25 | | |
| Recruiting | N/A | 80 | US | SMART GOALS Setting Tool/ Protocol | Northwell Health | PreDiabetes, Adolescent Obesity, Behavior, Health, Nutritional and Metabolic Diseases, Diet Habit, Lifestyle Risk Reduction | 11/25 | 12/25 | | |
| Stalvey, Michael |
NCT04002882: Role of Body Fat Distribution in Metabolic and Pulmonary Decline in Cystic Fibrosis (ORBIT-CF) |
|
|
| Recruiting | N/A | 90 | US | | Emory University, Cystic Fibrosis Foundation | Cystic Fibrosis | 05/25 | 05/25 | | |
BEGIN, NCT04509050: Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children |
|
|
| Recruiting | N/A | 210 | US | Ivacaftor or elexacaftor/tezacaftor/ivacaftor, Kalydeco or Trikafta, Vertex (VX)-770 or VX-445/VX-661/VX-770 | Sonya Heltshe, Cystic Fibrosis Foundation, University of Washington, University of Alabama at Birmingham | Cystic Fibrosis | 12/29 | 12/29 | | |
| Lee, Mary |
| Active, not recruiting | 3 | 187 | Canada, US | Escitalopram, Lexapro, Placebo, non-applicable | JHSPH Center for Clinical Trials, National Institute on Aging (NIA) | Dementia | 04/24 | 05/25 | | |
NCT02124174: Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS |
|
|
| Recruiting | 2 | 50 | US | Vidaza and Valproic Acid, Vidaza, Valproic Acid, Azacitadine | Patrick Stiff | Acute Myelogenous Leukemia AML, Myelodysplastic Syndrome MDS | 01/22 | 01/22 | | |
LIFU_TUD, NCT06405074: Low Intensity Focused Ultrasound for Tobacco Use Disorder: High Resolution Targeting of the Human Insula |
|
|
| Recruiting | N/A | 44 | US | low intensity focused ultrasound (LIFU) | Washington D.C. Veterans Affairs Medical Center | Tobacco Use Disorder | 03/26 | 03/26 | | |
| Recruiting | N/A | 25 | US | low intensity focused ultrasound (LIFU) | Washington D.C. Veterans Affairs Medical Center, National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) | Opioid Use Disorder, Chronic Back Pain, Anxiety | 09/25 | 09/25 | | |
| Soyka, Leslie A |
| Completed | 2 | 82 | Europe, US, RoW | LUM-201, rhGH Norditropin® pen (34 µg/kg) | Lumos Pharma, Lumos Pharma | Growth Hormone Deficiency | 09/24 | 09/24 | | |
| Hardy, Olga T |
| No trials found |
| Angelescu, Amanda |
| No trials found |
| Greeenman, Lisa |
| No trials found |
